-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Company Insights
Innovation and Patenting activity of Trillium Therapeutics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Trillium Therapeutics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Aortic and Vascular Graft Devices Pipeline Market Report Overview Aortic Stent and Vascular Graft Devices include Aortic Stent Grafts and Vascular Grafts. The Aortic and Vascular Graft Devices pipeline market research report provides comprehensive information about the Aortic and Vascular Graft devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments · Vascular Grafts · Abdominal Aortic Stent Grafts · Aortic Stent Grafts...
-
Company Profile
Trillium Therapeutics Inc – Company Profile
Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, a subsidiary of Pfizer Inc, is a clinical-stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company uses biologic and small molecule-based approaches to develop its portfolio. Its lead program, TTI-621 (intravenous), a SIRPαFc fusion protein is evaluated for the treatment of B and T-cell lymphomas and also for other blood cancers. Trillium is also developing TTI-621 (intratumoral) for solid cancers and T- cell lymphomas; TTI-622 for lymphoma...
Add to Basket -
Product Insights
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology comprises of reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on. The bacteriology pipeline market research report provides comprehensive information about the bacteriology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Canada Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment
GlobalData’s “Canada Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Canada Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment. The Canada Nephrology and Urology Devices Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is...
-
Product Insights
Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2018" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical trials on Relapsed Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Mycosis Fungoides Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H1, 2018" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...